valproic acid has been researched along with Cough in 5 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Valproic acid is a carboxylic acid used for the treatment of both seizure and mood disorders." | 5.32 | Valproic acid-induced eosinophilic pleural effusion. ( Federman, DG; Kravetz, JD, 2003) |
| "Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered." | 2.72 | Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. ( Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M, 2021) |
| "Valproic acid is a carboxylic acid used for the treatment of both seizure and mood disorders." | 1.32 | Valproic acid-induced eosinophilic pleural effusion. ( Federman, DG; Kravetz, JD, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emamikhah, M | 1 |
| Babadi, M | 1 |
| Mehrabani, M | 1 |
| Jalili, M | 1 |
| Pouranian, M | 1 |
| Daraie, P | 1 |
| Mohaghegh, F | 1 |
| Aghavali, S | 1 |
| Zaribafian, M | 1 |
| Rohani, M | 1 |
| Taşer, N | 1 |
| Sarıkaya, M | 1 |
| Maia, JM | 1 |
| Guedes, F | 1 |
| Aragão, I | 1 |
| Cardoso, T | 1 |
| Kravetz, JD | 1 |
| Federman, DG | 1 |
| Jacome, DE | 1 |
1 review available for valproic acid and Cough
| Article | Year |
|---|---|
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; | 2021 |
4 other studies available for valproic acid and Cough
| Article | Year |
|---|---|
An unusual case of pleuropericardial neutrophilic effusion associated with valproate.
Topics: Adult; Cough; Dyspnea; Echocardiography; Epilepsy; Female; Humans; Pericardial Effusion; Pericardioc | 2015 |
Eosinophilic pneumonia presenting as life-threatening ARDS.
Topics: Adult; Alprazolam; Antidepressive Agents, Second-Generation; Caustics; Cough; Drug Therapy, Combinat | 2015 |
Valproic acid-induced eosinophilic pleural effusion.
Topics: Adult; Anti-Bacterial Agents; Antimanic Agents; Ceftazidime; Chest Pain; Cough; Drainage; Drug Thera | 2003 |
La toux diabolique: neurogenic tussive crisis.
Topics: Carbamazepine; Cough; Female; Humans; Middle Aged; Multiple Sclerosis; Valproic Acid | 1985 |